Sexual-health peptides are unusual in this series: the flagship compound, bremelanotide, actually completed full clinical development and won FDA approval — making it one of the few grey-market peptides with a real, regulator-assessed evidence file. That file is worth reading closely, because it shows both what the compound genuinely does and how modest that is compared to its online reputation. The rest of the category — kisspeptin, gonadotropin-axis peptides, oxytocin — is legitimate endocrinology being retailed ahead of its evidence.
Sign in to read this Protocol Guide
The full Protocol Guide library is included with a free Peptide Data account. This guide is a 5-minute read.
Create free accountAlready have an account? Sign in.